---
title: Kincell Bio vs Synthego
slug_a: kincellbio
slug_b: synthego
site: cdmo
review_signal_gate: closed
canonical_path: /compare/kincellbio/synthego
generated_by: BioBM Editorial AI
---

# Kincell Bio vs Synthego

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Kincell Bio (kincellbio) is listed for cdmo. Leading cell therapy CDMO delivering GMP manufacturing, analytics, and CMC strategy from early development through commercial launch across purpose-built U.S. facilities.

Services: 5. Modalities: 1. Indications: 0. Locations: 2. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (5).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Synthego (synthego) is listed for cdmo. Synthego manufactures GMP-grade CRISPR components and molecular biology reagents for clinical and research applications, with 19 INDs cleared and 200+ clinical sgRNA batches produced.

Services: 4. Modalities: 2. Indications: 0. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (4).

Review summary: Review summary withheld until site-level review gate opens.